Orthofix International | OFIX - Current Assets


Orthofix International reported $394.17M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Accuray USD 303.6M 13.86M Sep/2025
AngioDynamics USD 172.27M 3.09M Feb/2025
Artivion USD 337.5M 18.68M Sep/2025
AtriCure USD 322.52M 21.41M Dec/2025
Dexcom USD 4.03B 1.19B Dec/2025
EDAP TMS EUR 44.35M 7.13M Sep/2025
Globus Medical USD 2.13B 201.25M Dec/2025
Hologic USD 3.84B 175.3M Dec/2025
Inogen USD 203.72M 594K Sep/2025
Insulet USD 1.91B 54.6M Dec/2025
Integra LifeSciences USD 1.16B 15.96M Dec/2025
J&J USD 55.62B 1.01B Dec/2025
Medtronic USD 24B 773M Sep/2025
Mesa Laboratories USD 105.63M 8.2M Dec/2025
Orthofix International USD 394.17M 1.66M Sep/2025
Plus Therapeutics USD 9.83M 1.75M Dec/2023
Smith & Nephew USD 4.63B 169M Dec/2025
STAAR Surgical USD 311.54M 9.66M Dec/2025
Stryker USD 14.76B 1.04B Dec/2025
Surmodics USD 81.3M 948K Sep/2024
Tandem Diabetes Care USD 618.14M 1.2M Dec/2025
Teleflex USD 1.94B 47.65M Dec/2025
Veracyte USD 488.38M 39.15M Dec/2025
Zimmer Biomet Holdings USD 5.12B 715M Dec/2025